Concepedia

Donald J. Kyle

DJ

44

Publications

1.6K

Citations

24

H-Index

1977

Active since

Affiliations

Purdue Pharma (United States)(Current)

Nova Research Company (United States)

Purdue Pharma (Canada)

Universidade Federal de Santa Catarina

Freeport-McMoRan (United States)

Donald J. Kyle is an author at Purdue Pharma (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1977–2023

44

Publications

44

Stable Expression of the Human Kinin B1 Receptor in Chinese Hamster Ovary Cells

Caroline E. Austin, H. Robinson, Sarvajit Chakravarty et al. · Journal of Biological Chemistry · 1997 · 123 citations · Full text

Antinociceptive profile of the pseudopeptide B<sub>2</sub>bradykinin receptor antagonist NPC 18688 in mice

Clovis R. Corrêa, Donald J. Kyle, Sarvajit Chakraverty et al. · British Journal of Pharmacology · 1996 · 107 citations · Full text

Roles of μ-Opioid Receptors and Nociceptin/Orphanin FQ Peptide Receptors in Buprenorphine-Induced Physiological Responses in Primates

Colette M Cremeans, Erin Gruley, Donald J. Kyle et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 95 citations · Full text

Design and conformational analysis of several highly potent bradykinin receptor antagonists

Donald J. Kyle, Jennifer A. Martin, Stephen G. Farmer et al. · Journal of Medicinal Chemistry · 1991 · 85 citations

, , +21

Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.

John W. Ferkany, Donald J. Kyle, Jonathon M. Willets et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 78 citations

Rows per page

1–5 of 44